- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03965429
Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation (SIA-CSH)
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Dominique Genre, MD
- Phone Number: 0491223778
- Email: drci.up@ipc.unicancer.fr
Study Contact Backup
- Name: Margot Berline, MSc, MBA
- Phone Number: 0491223314
- Email: drci.up@ipc.unicancer.fr
Study Locations
-
-
Bouches-du Rhône
-
Marseille, Bouches-du Rhône, France, 13009
- Recruiting
- Institut Paoli-Calmettes
-
Principal Investigator:
- Raynier DEVILLIER
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Allogeneic hematopoietic stem cell transplant for hematological malignancy
- Patients 18 years of age or older
- Signed consent to participation
- Membership in a social security scheme, or beneficiary of such a scheme.
Exclusion Criteria:
- A person of legal age subject to a legal protection measure (major under guardianship, curatorship or court bail), or unable to express consent (language criteria included).
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Donor
In the case of a transplant from an intrafamily donor (genoid or haploid), we will also collect blood samples from the donor.
|
In the case of a transplant from an intrafamily donor (genoid or haploid), we will also collect blood samples from the donor. A single blood sample of 28 mL (7 EDTA tubes) will be made. In order not to represent an additional sample for the donor, this sample will be taken before the mobilization of the hematopoietic stem cells, during the biological assessment required for the biological donation qualification. |
Receiver
Systematic longitudinal collection of blood samples for any patient receiving an allogeneic CSH transplant in our facility, regardless of donor category selected and type of graft used
|
Some sampling times will be systematic, while others will only be performed in the presence of specific post-transplant clinical events (eg relapse, GVH ...).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evolution of the immune blood populations in patients who have received allogeneic hematopoietic stem cell transplantation.
Time Frame: 5 years after HSC transplantation
|
longitudinal study of the immune subpopulations of allografted patients for hematological malignancies.
|
5 years after HSC transplantation
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Raynier Devillier, MD, PhD, Institut Paoli-Calmettes
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SIA-CSH-IPC 2015-017
- 2019-000814-13 (EudraCT Number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malignant Hemopathy
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la Loire; Université Jean Monnet de Saint-EtienneRecruiting
-
Gustave Roussy, Cancer Campus, Grand ParisRecruiting
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la Loire; Institut de Recherche Biomedicale des...TerminatedBone Metastasis | Malignant HemopathyFrance
-
Assistance Publique - Hôpitaux de ParisTerminatedMalignant Hemopathy | Duration of Neutropenia Following Chemotherapy > 10 DaysFrance
-
University Hospital, ToulouseJanssen, LP; Ligue contre le cancer, FranceNot yet recruiting
-
Hospira, now a wholly owned subsidiary of PfizerCompletedSolid Tumors | Malignant Hemopathy | Chemotherapy-induced Febrile Neutropenia (FN)France
-
Centre Hospitalier Universitaire, AmiensUnknown
-
Imagine InstituteTerminated
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm | Unresectable Malignant Neoplasm | Advanced Malignant NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
Clinical Trials on Blood samples (additional tubes from care) at inclusion
-
Centre Hospitalier Universitaire de BesanconRecruitingSARS-CoV-2 InfectionFrance
-
Centre Hospitalier Universitaire DijonCompletedInfectious Disease | Solid Tumor | Hemopathy | Horton's Disease | NeoplasiaFrance
-
Centre Hospitalier Universitaire DijonCompleted
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingHypertension, Pulmonary | BiomarkersFrance
-
Nantes University HospitalCompletedPatients Receiving Animal-derived Bioprosthetic Heart ValvesFrance, Canada, Italy, Spain
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; CSL Behring and other collaboratorsNot yet recruitingLiver CirrhosisFrance
-
Institut Paoli-CalmettesNot yet recruitingPAPILLARY AND MUCINOUS INTRACANAL TUMORS OF THE PANCREAS
-
Centre Hospitalier de CayenneUniversity Hospital, Montpellier; Direction Générale de l'Offre de Soins; Hospital...RecruitingHepatitis B, Chronic | AdultsFrench Guiana
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed